A bill (S. 2668) introduced by Sen. David Vitter (R-LA) would require that companies incorporate RFID tagging technology, tamper-indicating technologies, and security packaging into all prescription drugs. These technologies would be used only to authenticate the integrity of the drugs and would not be used to transmit any identifying information about healthcare practitioners, consumers, or advertisers. S. 2668 has no cosponsors and has been referred to the Senate Health, Education, Labor, and Pensions Committee.
Comments